ESMO26: MSD and Moderna drop cancer vaccine trial data early
MSD and Moderna have reported full Phase III results for their personalised cancer vaccine, but both companies’ shares fell after…
News
AbbVie’s skin disease drug posts Phase III win as market competition heats up
Prilenia and Ferrer secure EU authorisation for Phase III HD trial
Granata Bio concludes screening in Phase III GRACE trial for IVF
Roivant eyes Lisraya label expansion on Phase III uveitis win
HealthBio begins multi-centre trial of Inflamexa for PTLDS
Lynch’s rhPDGF-BB IND secures FDA clearance for Phase II trial
Sanofi & Teva’s IBD drug prompts long-term clinical remission in Phase IIb trial
